Good afternoon, the FDA today approved aducanumab–the first new therapy for Alzheimer’s in 13 years. University of Miami experts, Including Dr. James Galvin, led clinical trials to test the pioneering drug with patients and can discuss why the aducanumab is a promising game changer and the parameters for treatment. Dr. Galvin, is the Director of the University of Miami’s Center for Comprehensive Brain Health.
Let me know if you would be interested in scheduling an interview. See Dr. Galvin’s profile below.
https://med.miami.edu/en/departments/neurology/divisions/comprehensive-center-for-brain-health/message-from-the-chief
